Shah Investors Home Ltd
- Market Cap ₹ 291 Cr.
- Current Price ₹ 137
- High / Low ₹ 180 / 128
- Stock P/E 21.6
- Book Value ₹
- Dividend Yield 0.00 %
- ROCE 11.4 %
- ROE 7.59 %
- Face Value ₹ 10.0
Pros
Cons
- Company has a low return on equity of 11.3% over last 3 years.
- Debtor days have increased from 79.5 to 137 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Financial Services Financial Services Capital Markets Stockbroking & Allied
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| 79 | 94 | 71 | |
| Sales growth | +19% | -24% | |
| 52 | 58 | 49 | |
| Operating Profit | 27 | 36 | 22 |
| OPM % | 34% | 38% | 31% |
| 0 | 0 | 1 | |
| Interest | 2 | 3 | 3 |
| Depreciation | 1 | 2 | 2 |
| Profit before tax | 24 | 31 | 18 |
| Tax % | 25% | 25% | 28% |
| 18 | 23 | 13 | |
| EPS in Rs | 11.38 | 14.85 | 8.38 |
| Dividend Payout % | 9% | 7% | 18% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -24% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -44% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 11% |
| Last Year: | 8% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| Equity Capital | 16 | 16 | 16 |
| Reserves | 135 | 152 | 164 |
| 4 | 6 | 18 | |
| 145 | 129 | 106 | |
| Total Liabilities | 299 | 303 | 304 |
| 22 | 22 | 24 | |
| CWIP | 1 | 1 | 3 |
| Investments | 72 | 77 | 83 |
| 204 | 202 | 195 | |
| Total Assets | 299 | 303 | 304 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| 110 | -32 | -20 | |
| -2 | -11 | -10 | |
| -7 | -2 | 9 | |
| Net Cash Flow | 102 | -45 | -21 |
| Free Cash Flow | 109 | -34 | -25 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 430% | -62% | -61% |
Ratios
Consolidated / View Standalone
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| Debtor Days | 36 | 65 | 137 |
| Inventory Days | |||
| Days Payable | |||
| Cash Conversion Cycle | 36 | 65 | 137 |
| Working Capital Days | -579 | -399 | -342 |
| ROCE % | 21% | 11% |
Documents
Announcements
-
Board Meeting Intimation for Considering And Approving The Standalone And Consolidated Unaudited Financial Results Of The Company For The Quarter And Half-Year Ended September 30, 2026, Along With The Limited Review Report.
- Board meets November 14, 2026 to approve Q2 and half-year results; trading window closed from October 6.
-
Announcement Under Regulation 30 Of SEBI (LODR) - Appointment Of System Auditor
- Board approved Q1 results, acquired 71,857 Ficus Food Lab shares for 6.25%, and appointed auditors.
-
Announcement Under Regulation 30 Of SEBI (LODR) - Appointment Of Internal Auditor
- Board approved Q1 FY27 results, 6.25% Ficus Food Lab acquisition, and auditor appointments.
-
Announcement under Regulation 30 (LODR)-Acquisition
- Board approved Q1 FY27 results and 6.25% acquisition in Ficus Food Lab on 27 Oct 2026.
-
Results -Financial Result For June 30, 2026
- Board approved Q1 FY27 results, 6.25% stake acquisition in Ficus Food Lab, and auditor appointments.